Stanley Frankel
Patrimonio netto: 292 835 $ in data 31/10/2026
Patrimonio netto: 292 835 $ in data 31/10/2026
Stanley R.
Frankel is an Independent Non-Executive Director at Precision BioSciences, Inc. since 2021.
Dr. Frankel is an Independent Director at CREATE Medicines, Inc. (Massachusetts) since 2022.
Formerly, Dr. Frankel was SVP-Global Drug Development & Cellular Therapy at Bristol Myers Squibb Co. from 2019 to 2020.
Dr. Frankel was VP, Head-Clinical Research & Development at Celgene Corp.
from 2015 to 2019.
Dr. Frankel was Chief Medical Officer at Cytovia Therapeutics, Inc. Education includes a doctorate from Northwestern University and an undergraduate degree from Harvard College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/09/2026 | 41.478 ( 0,17% ) | 292 835 $ | 31/10/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 12/04/2021 |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Direttore/Membro del Consiglio | 30/06/2022 |
| Società | Posizione | Fine |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/10/2020 |
| CELGENE | Direttore Tecnico/Scientifico/R&S | 01/11/2019 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Precision BioSciences, Inc.
Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale